Publications by Dr. Emory

  • Monoamine Oxidase Inhibition in a Patient With Type I Diabetes and Depression
    Emory H. and Mizrahi, N, 2016 Journal of Diabetes Science and Technology. DOI: 10.1177/1932296816638106
  • Glycaemic Control By Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes
    Emory H. and Mizrahi, N, 2016 Journal of Diabetes & Vascular Research Disease.
    DOI: 10.1177/1479164116675492
  • Quantitative EEG and Current Source Density Analysis of Combined Antiepileptic Drugs and Dopaminergic Agents in Genetic Epilepsy
    Emory WH, Wells C, and Mizrahi N. Clin EEG Neurosc. 2015; 46(3): 256-262. doi: 10.1177/1550059414532253
    (Spring 2015)
  • EEG Topography and LORETA Tomography in Neuropathology and Treatment of Genetic Epilepsy EEG W. Hamlin Emory, M.D., Christopher Wells, B.A., Neptune Mizrahi, Ph.D.
    Poster Presentation at the International Conference on Basic and Clinical Multimodal Imaging, Geneva, Switzerland, September 2013.
  • QEEG Features & Medicinal Response in Epilepsy W. Hamlin Emory, M.D.
    Presented at the International Pharmaco-EEG Society Symposium on EEG-based Personalized Medicine, New York, N.Y; October 2012.
  • EEG and QEEG as an Adjunct to Clinical Assessment Predicts Response to Atypical Treatment Options. W. Hamlin Emory, M.D., Mark Shatsky, D.O., C. Wells. B.S.
    Poster Presentation at the 22nd Annual ANPA Conference, Denver, March 2011.
  • Questioning the Risk Profile of Selegiline Hydrochloride. W. Hamlin Emory, M.D., Mark Shatsky, D.O., C. Wells. B.S. Poster Presentation at the 164th Annual APA Conference, Honolulu 2011 and Institute on Psychiatric Services Conference, San Francisco, October 2011.
  • An Alternative to Standardized Psychiatric Prescribing By W. Hamlin Emory, M.D.
    published in The Eating Disorder Sourcebook 3rd ed. by Carolyn Costin, M.A., M.Ed., M.F.T. 2007. 291-294.
  • EEG Guidance of Psychopharmacologic Treatment: Multi-site Experience. Schiller MJ, Emory WH, Shaffer J, Hamilton JT, Hoffman DA, Davis A. Suffin SS.(May, 2005).
    Poster No. 10 for 158th Annual Meeting of American Psychiatric Association, Atlanta, GA.
  • Referenced-EEG in the Treatment of Eating Disorders By Mark Schiller, M.D., W. Hamlin Emory, M.D., Stephen C. Suffin, M.D. 2004; Presented at the 44th Annual NCDEU Conference
  • Neurometric Subgroups in Attentional and Affective Disorders and Their Association with Pharmacotherapeutic OutcomeBy Stephen C. Suffin and W. Hamlin Emory
    Source: Clinical Electroencephalography ©1995 Vol. 26 No. 2 
Latest News

December 2017

Appearance: Dr. Hamlin Emory appears in Documentary Series The Menendez Murders: Erik Tells All, Season 1, Episode 3;

April 2017

Lecture: Inclusive Medical Approach with EEG & QEEG Features Predict Catecholamine Response in Idiopathic Genetic Epilepsies (IGE);
SBMT Annual Meeting, Los Angeles Millennial Biltmore, April 18, 2017


Lecture: Neuroplasticity in Medical Illnesses and Psychiatric Syndromes;
SBMT Annual Meeting, Los Angeles Millennial Biltmore, April 20, 2017


November 2016

Glycaemic Co< (Journal of Diabetes & Vascular Research Disease. DOI: 10.1177/1479164116675492)


March 2016

Monoamine Oxidase Inhibition in a Patient With Type I Diabetes and Depression Emory H. and Mizrahi, N, // (Journal of Diabetes Science and Technology. DOI: 10.1177/1932296816638106)


January 2016

Dr. Hamlin Emory Speaks in Washington State - Finding and Fixing Unrecognized Brain Differences
https://vimeo.com/154468931


Fall 2015

Actor Dick Van Dyke publishes a book entitled, "Keep Moving and Other Tips and Truths About Aging," in which he describes his treatment by Dr. Hamlin Emory.
http://www.amazon.com/Keep-Moving-Other-Truths-About/dp/1602862966


Spring 2015

Quantitative EEG and Current Source Density Analysis of Combined Antiepileptic Drugs and Dopaminergic Agents in Genetic Epilepsy W. Hamlin Emory, Christopher Wells and Neptune Mizrahi. // (Accepted for publication Spring 2015)


Patient Testimonials